Targeting B7-H3 enhances the efficacy of neoantigen-based cancer vaccine in combination with radiotherapy
Abstract The clinical response to immune checkpoint blockade (ICB) is limited in the majority of patients with colorectal cancer. These immune checkpoint proteins may not only inhibit T-cell-mediated antitumor immunity but also attenuate antigen presentation, including mutation-associated neoantigen...
Saved in:
| Main Authors: | Tao-Wei Ke, Chia-Yi Chen, William Tzu-Liang Chen, Yuan-Yao Tsai, Shu-Fen Chiang, Chi-Hsien Huang, Yu-Sen Lin, Te-Hong Chen, Tsung-Wei Chen, Ji-An Liang, K. S. Clifford Chao, Kevin Chih-Yang Huang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-04-01
|
| Series: | npj Vaccines |
| Online Access: | https://doi.org/10.1038/s41541-025-01132-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CHK1 inhibition increases the therapeutic response to radiotherapy via antitumor immunity in ARID1A-deficient colorectal cancer
by: Jhen-Yu Chen, et al.
Published: (2025-08-01) -
Recent Development and Clinical Application of Cancer Vaccine: Targeting Neoantigens
by: Ren-You Pan, et al.
Published: (2018-01-01) -
A phase II randomized trial of individualized neoantigen peptide vaccine combined with unusual radiotherapy (iNATURE) in advanced solid tumors-GCOG0028
by: Yan Zhang, et al.
Published: (2025-08-01) -
Neoantigen architectures define immunogenicity and drive immune evasion of tumors with heterogenous neoantigen expression
by: Stefani Spranger, et al.
Published: (2024-11-01) -
Neoantigen enriched biomimetic nanovaccine for personalized cancer immunotherapy
by: Yuwei Li, et al.
Published: (2025-05-01)